The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 17th 2024
Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Meta-analysis Aims to Compare Antidiabetic Medications in T2D Population
June 30th 2020Metformin-based therapy may be an optimal first-line treatment for patients with type 2 diabetes (T2D) and low cardiovascular risk, according to a systematic review and network meta-analysis published in Annals of Internal Medicine.
Read More
Dr Tara Kaushal Discusses Benefits of Active Technology Use as a Health Intervention for T1D
June 26th 2020Peer support is a huge advantage of technological health interventions for teens with type 1 diabetes (T1D), while integrating technology with physical activities is important when promoting healthy lifestyles, said Tara Kaushal, MD, physician and clinical researcher at Joslin Diabetes Center.
Watch
Study Highlights Variation in Second-Generation Diabetes Drug Use Among Medicare Enrollees
June 22nd 2020Among Medicare enrollees, there was substantial between-practice variation in the use of second-generation diabetes drugs between 2007 and 2015, according to a study published in JAMA Network Open. Data also revealed a concentration of use among a few prescribers and practices, who were responsible for widespread early diffusion.
Read More
Jennifer N. Clements, PharmD, is a clinical pharmacist in diabetes transition with Spartanburg Regional Healthcare System in Spartanburg, South Carolina. Clements is a board-certified pharmacotherapy specialist, board-certified ambulatory care pharmacist, and certified diabetes care and education specialist. She is currently developing a pharmacy service focused on the inpatient management of diabetes. An editor from The American Journal of Managed Care® recently conducted an interview with Clements to discuss strategies for improving transitions of care for patients with diabetes.
Read More
DPP Continues to Yield Positive Results, New DPPOS Data Show
June 17th 2020New results from the Diabetes Prevention Program Outcomes Study (DPPOS), presented at the American Diabetes Association’s 80th Scientific Sessions, showed persistent reductions in type 2 diabetes (T2D) development over an average 22-year follow-up period.
Read More
VERTIS CV: Ertugliflozin Falls Short of SGLT2s on CV Outcomes, Despite Promise in Heart Failure
June 16th 2020A finding that ertugliflozin produced a 30% drop in heart failure hospitalization risk fell outside the study’s primary and secondary end points; here, the drug performed within range of its class, the sodium glucose co-transporter 2 (SGLT2) inhibitors.
Read More
Starting Insulin, GLP-1 at Same Time Brings Better Glycemic Control, Real-World Data Show
June 15th 2020Selected abstracts from the American Diabetes Association's 80th Scientific Sessions discuss when to add injectable therapy, how patients who switched to semaglutide lost more weight and gained glycemic control, and offered results from an early-phase study on a monoclonal antibody that may preserve B-cell function.
Read More
COVID-19 Is Changing the A1C vs Time-in-Range Debate, Expert Says
June 15th 2020During a joint symposium on Saturday, held as part of the 80th American Diabetes Association Scientific Sessions and hosted by JDRF President and CEO Aaron Kowalski, PhD, experts debated the merits and pitfalls of how to measure glycemic control and overall health among persons with diabetes. Which is better, they asked: the traditional measure of glycated hemoglobin or the newer measure, time-in-range?
Read More
Dr Robert Gabbay Reflects on Insulin Cost Caps for Some Medicare Beneficiaries
June 14th 2020The announcement of a $35 per month out-of-pocket cap for insulin for some individuals with Medicare is a real victory for the American Diabetes Association and for people with diabetes, said Robert Gabbay, MD, PhD, chief medical and scientific officer of the American Diabetes Association.
Watch
Racial Disparities Persist in Maternal Morbidity, Mortality and Infant Health
June 14th 2020American women die in childbirth at a higher rate than in any other developed country, while non-Hispanic Black women are more than 3 times more likely to have a maternal death than white women in the United States, according to a review presented at the American Diabetes Association’s 80th Scientific Sessions.
Read More
Session Details Interrelations of Youth Obesity, Type 2 Diabetes
June 13th 2020Obesity contributes to development of youth-onset type 2 diabetes (T2D) and can lead to detrimental health outcomes in adulthood. Researchers explored this relationship and offered insights on addressing the problem during a session at the American Diabetes Association’s (ADA) 80th Scientific sessions, held virtually due to coronavirus disease 2019 (COVID-19).
Read More
Can a Digital Health Intervention Increase Heart-Healthy Behaviors in Youth With Type 1 Diabetes?
June 13th 2020The aim of this feasibility study was to determine whether digital health use via smartphones, a platform that adolescents are more engaged with than other age groups, could aid in teaching youth more about cardiovascular risks, and promote uptake of this knowledge so individuals increase heart healthy behaviors, said Tara Kaushal, MD, physician and clinical researcher at Joslin Diabetes Center.
Read More
Cardiovascular Benefits of Vascepa Greater for Those With Diabetes, New REDUCE-IT Data Show
June 13th 2020When it comes to diabetes, lead study author Deepak L. Bhatt, MD, MPH, said clinicians and payers should weigh the considerable costs of what happens when a patient suffers a heart attack or stroke when deciding on a treatment regimen.
Read More
This Week in Managed Care: June 12, 2020
June 12th 2020This week, the top managed care news included HHS distributing COVID-19 funds to Medicaid and CHIP providers; the National Kidney Foundation issues a statement on health disparities and racial violence; a preview of our coverage of the American Diabetes Association 2020 Virtual Scientific Sessions.
Watch
Dr Robert Gabbay Discusses New ADA Role; Virtual Scientific Sessions
June 11th 2020One advantage of conducting an online scientific conference is that more individuals will gain access to information presented at the meeting, said Robert Gabbay, MD, PhD, the newly appointed chief medical and scientific officer of the American Diabetes Association.
Watch
Among patients with type 2 diabetes (T2D), concurrent cardiovascular-, heart failure–, or renal-related hospitalization presents significant disease burden leading to poor quality of life.
Read More
Experts Issue Guidance on Concurrent COVID-19, Diabetes Treatment
June 10th 2020Patients hospitalized for coronavirus disease 2019 (COVID-19) who have diabetes account for more than 20% of individuals admitted to intensive care units, according to new guidance published in the Journal of Clinical Endocrinology & Metabolism.
Read More
Diabetes Educators Release Updated Report on DSMES Accessibility, Usage
June 9th 2020The Association of Diabetes Care & Education Specialists (ADCES) released a consensus report outlining strategies health care stakeholders can follow to increase access to and utilization of diabetes self-management education and support (DSMES).
Read More
How Does Medication Adherence Affect Mortality Risk in Patients With Colorectal Cancer, Diabetes?
June 2nd 2020For individuals with both diabetes and colorectal cancer, high adherence to oral diabetes medication was associated with a significantly reduced risk of overall mortality compared with lower adherence, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
Read More
Out-of-Pocket Insulin Costs Remain Stable for the Privately Insured
June 1st 2020Insulin out-of-pocket costs remained relatively flat between 2006 and 2017 among privately insured patients, despite increased insulin prices paid by insurers, according to research published in JAMA Internal Medicine.
Read More
A bill introduced yesterday by Representative Maxine Waters, with support from the American Diabetes Association, would eliminate cost sharing for patients with diabetes requiring insulin amid the coronavirus disease 2019 pandemic; White House officials have decided to not release economic projections this summer for the first time since the 1970s; CDC provides recommendations for employers returning to the workplace.
Read More